P
Paolo Tarantino
Researcher at European Institute of Oncology
Publications - 17
Citations - 569
Paolo Tarantino is an academic researcher from European Institute of Oncology. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 5, co-authored 17 publications receiving 105 citations. Previous affiliations of Paolo Tarantino include University of Milan.
Papers
More filters
Journal ArticleDOI
HER2-Low Breast Cancer: Pathological and Clinical Landscape.
Paolo Tarantino,Paolo Tarantino,Erika Hamilton,Sara M. Tolaney,Javier Cortes,Stefania Morganti,Stefania Morganti,Emanuela Ferraro,Emanuela Ferraro,Antonio Marra,Antonio Marra,Giulia Viale,Giulia Viale,Dario Trapani,Dario Trapani,Fatima Cardoso,Frédérique Penault-Llorca,Giuseppe Viale,Giuseppe Viale,Fabrice Andre,Giuseppe Curigliano,Giuseppe Curigliano +21 more
Book ChapterDOI
Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer
Stefania Morganti,Paolo Tarantino,Emanuela Ferraro,Paolo D'Amico,Bruno Achutti Duso,Giuseppe Curigliano +5 more
TL;DR: In this article, the authors discuss the history, available techniques and applications of NGS in oncology, with a particular referral to the Personalized Medicine (PM) approach and the emerging role of the research field of pharmacogenomics.
Journal ArticleDOI
Antibody-drug conjugates: Smart chemotherapy delivery across tumor histologies.
Paolo Tarantino,Paolo Tarantino,Roberto Carmagnani Pestana,Chiara Corti,Chiara Corti,Shanu Modi,Aditya Bardia,Sara M. Tolaney,Javier Cortes,Jean-Charles Soria,Giuseppe Curigliano,Giuseppe Curigliano +11 more
TL;DR: In this article, the authors summarize the current approvals of antibody-drug conjugates (ADCs) by the US Food and Drug Administration focusing on solid tumors and discuss the challenges and opportunities posed by the multihistological expansion of ADCs.
Journal ArticleDOI
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates: A Review
Paolo Tarantino,Paolo Tarantino,Shanu Modi,Sara M. Tolaney,Javier Cortes,Erika Hamilton,Sung-Bae Kim,Masazaku Toi,Fabrice Andre,Giuseppe Curigliano,Giuseppe Curigliano +10 more
TL;DR: In this article, a review summarizes the current knowledge on the pathogenesis and epidemiologic characteristics of anti-ERBB2 ADC-related lung toxicity, proposing strategies for its diagnosis and treatment.
Journal ArticleDOI
Therapeutic cancer vaccines revamping: technology advancements and pitfalls.
G. Antonarelli,Chiara Corti,Chiara Corti,Paolo Tarantino,Paolo Tarantino,Liliana Ascione,Liliana Ascione,Javier Cortes,Pedro Romero,Elizabeth A. Mittendorf,Mary L. Disis,Giuseppe Curigliano,Giuseppe Curigliano +12 more
TL;DR: In this paper, the main technological advancements as well as major issues to tackle in the development of cancer vaccines are outlined, putting into perspective the future of cancer vaccinology and possible applications for unmet clinical needs.